Skip to content
User

Daniel Loeb

Third Point

Daniel Loeb Inogen Inc stake

total: 588

Third Point INGN trades

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2021 Q3
Held for:
1 quarter
Latest activity:
2021 Q4
According to 2026 Q2 report, Daniel Loeb doesn't hold any Inogen Inc (INGN) shares. To date, the estimated cost basis is nearly $43.1 for "buy" trades and estimated average "sell" price is $43.1. Third Point first purchased INGN in 2021 Q3, initially acquiring 73,675 shares. Since the initial investment in Inogen Inc (INGN), Third Point has made 1 more transaction.

When did Daniel Loeb sell Inogen Inc (INGN)?

Daniel Loeb sold off the entire Inogen Inc (INGN) position in 2021 Q4.

When did Daniel Loeb buy Inogen Inc (INGN)?

Daniel Loeb first invested in Inogen Inc (INGN) in 2021 Q3 at the reported quarter-end price of $43.09 per share.

What's the cost basis of Third Point's INGN stake?

The estimated cost basis for Inogen Inc (INGN) stake is around $43.10 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$43.10
Weighted AVG sell price:
$43.10

Daniel Loeb's historical trades in Inogen Inc

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2021 Q4
0.00%
0
$43.09
-100% (-73,675)
-0.02%
2021 Q3
0.02%
73,675
$43.09
$3,175,000
new
+0.02%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.